These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 27989722)
21. Summary and Recommendations from the National Institute of Allergy and Infectious Diseases (NIAID) Workshop "Gonorrhea Vaccines: the Way Forward". Wetzler LM; Feavers IM; Gray-Owen SD; Jerse AE; Rice PA; Deal CD Clin Vaccine Immunol; 2016 Aug; 23(8):656-63. PubMed ID: 27335384 [TBL] [Abstract][Full Text] [Related]
22. A Human-Based Integrated Framework for Alzheimer's Disease Research. Pistollato F; Cavanaugh SE; Chandrasekera PC J Alzheimers Dis; 2015; 47(4):857-68. PubMed ID: 26401764 [TBL] [Abstract][Full Text] [Related]
23. Proceedings of the Second Workshop on Theory meets Industry (Erwin-Schrödinger-Institute (ESI), Vienna, Austria, 12-14 June 2007). Hafner J J Phys Condens Matter; 2008 Feb; 20(6):060301. PubMed ID: 21693862 [TBL] [Abstract][Full Text] [Related]
24. Enabling a shift towards a human-relevant and predictive paradigm for biomedical research and drug discovery in India. Parvatam S; Bharadwaj S; Poojary B ALTEX; 2021; 38(3):507-509. PubMed ID: 34282463 [No Abstract] [Full Text] [Related]
25. [Transforming medicine through discovery. Major trends in biomedical research]. Zerhouni EA Bull Acad Natl Med; 2007 Nov; 191(8):1685-94. PubMed ID: 18666466 [TBL] [Abstract][Full Text] [Related]
26. The Palestinian health research system: who orchestrates the system, how and based on what? A qualitative assessment. AlKhaldi M; Alkaiyat A; Abed Y; Pfeiffer C; Halaseh R; Salah R; Idries M; Abueida S; Idries I; Jeries I; Meghari H; Shaar A; Tanner M; Haj-Yahia S Health Res Policy Syst; 2018 Jul; 16(1):69. PubMed ID: 30064510 [TBL] [Abstract][Full Text] [Related]
27. Innovation Partnership for a Roadmap on Vaccines in Europe (IPROVE): A vision for the vaccines of tomorrow. Medaglini D; De Azero MR; Leroy O; Bietrix F; Denoel P Vaccine; 2018 Feb; 36(9):1136-1145. PubMed ID: 29395517 [TBL] [Abstract][Full Text] [Related]
28. Barriers to Alzheimer disease drug discovery and development in academia. Van Eldik LJ; Koppal T; Watterson DM Alzheimer Dis Assoc Disord; 2002; 16 Suppl 1():S18-28. PubMed ID: 12070358 [TBL] [Abstract][Full Text] [Related]
29. Isocyanates and human health: multistakeholder information needs and research priorities. Lockey JE; Redlich CA; Streicher R; Pfahles-Hutchens A; Hakkinen PB; Ellison GL; Harber P; Utell M; Holland J; Comai A; White M J Occup Environ Med; 2015 Jan; 57(1):44-51. PubMed ID: 25563538 [TBL] [Abstract][Full Text] [Related]
30. The role of public-sector research in the discovery of drugs and vaccines. Stevens AJ; Jensen JJ; Wyller K; Kilgore PC; Chatterjee S; Rohrbaugh ML N Engl J Med; 2011 Feb; 364(6):535-41. PubMed ID: 21306239 [TBL] [Abstract][Full Text] [Related]
31. Next generation testing strategy for assessment of genomic damage: A conceptual framework and considerations. Dearfield KL; Gollapudi BB; Bemis JC; Benz RD; Douglas GR; Elespuru RK; Johnson GE; Kirkland DJ; LeBaron MJ; Li AP; Marchetti F; Pottenger LH; Rorije E; Tanir JY; Thybaud V; van Benthem J; Yauk CL; Zeiger E; Luijten M Environ Mol Mutagen; 2017 Jun; 58(5):264-283. PubMed ID: 27650663 [TBL] [Abstract][Full Text] [Related]
32. Lessons from a Recovering Academic. Ehlers MD Cell; 2016 May; 165(5):1043-1048. PubMed ID: 27203106 [TBL] [Abstract][Full Text] [Related]
33. Academia-industry partnerships: are we ready for new models of partnership?: the point of view of the EORTC, an academic clinical cancer research organisation. Lacombe D; Burock S; Meunier F Eur J Cancer; 2013 Jan; 49(1):1-7. PubMed ID: 23079476 [No Abstract] [Full Text] [Related]
34. Cardiovascular drug development: is it dead or just hibernating? Fordyce CB; Roe MT; Ahmad T; Libby P; Borer JS; Hiatt WR; Bristow MR; Packer M; Wasserman SM; Braunstein N; Pitt B; DeMets DL; Cooper-Arnold K; Armstrong PW; Berkowitz SD; Scott R; Prats J; Galis ZS; Stockbridge N; Peterson ED; Califf RM J Am Coll Cardiol; 2015 Apr; 65(15):1567-82. PubMed ID: 25881939 [TBL] [Abstract][Full Text] [Related]
35. Data-intensive drug development in the information age: applications of Systems Biology/Pharmacology/Toxicology. Kiyosawa N; Manabe S J Toxicol Sci; 2016; 41(Special):SP15-SP25. PubMed ID: 28003636 [TBL] [Abstract][Full Text] [Related]
36. Guidance for identification and treatment of individuals with attention deficit/hyperactivity disorder and autism spectrum disorder based upon expert consensus. Young S; Hollingdale J; Absoud M; Bolton P; Branney P; Colley W; Craze E; Dave M; Deeley Q; Farrag E; Gudjonsson G; Hill P; Liang HL; Murphy C; Mackintosh P; Murin M; O'Regan F; Ougrin D; Rios P; Stover N; Taylor E; Woodhouse E BMC Med; 2020 May; 18(1):146. PubMed ID: 32448170 [TBL] [Abstract][Full Text] [Related]
37. [The use of transgenic animals in biomedical research in Germany. Part 2: Ethical evaluation of the use of transgenic animals in biomedical research and perspectives for the changeover in research to research animal-free methods]. Sauer UG; Kolar R; Rusche B ALTEX; 2006; 23(1):3-16. PubMed ID: 16477343 [TBL] [Abstract][Full Text] [Related]
38. Making Basic Science Studies in Glaucoma More Clinically Relevant: The Need for a Consensus. Toris CB; Gelfman C; Whitlock A; Sponsel WE; Rowe-Rendleman CL J Ocul Pharmacol Ther; 2017 Sep; 33(7):501-518. PubMed ID: 28777040 [TBL] [Abstract][Full Text] [Related]
39. Induced pluripotent stem cells: opportunities as research and development tools in 21st century drug discovery. Rowntree RK; McNeish JD Regen Med; 2010 Jul; 5(4):557-68. PubMed ID: 20632859 [TBL] [Abstract][Full Text] [Related]